Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220021298 220017291 1.56 7.5 Disease modification (D) 2016-10-22 2016-12-03 NB HRNBL-1 COJEC Ind COURSE C 02 N 220023478 NOT MATCHED
220021299 220006188 1.88 52.5 Palliative (P) null 2018-10-19 Hydroxycarbamide N null 220023489 HYDROXYCARBAMIDE
220021300 220006215 1.78 67.2 Curative (C) null 2016-05-17 Cytarabine Low Dose Y N 220023606 CYTARABINE
220021301 220013346 0 0 Disease modification (D) 2016-10-22 2016-10-22 Hydroxycarbamide 02 null 220023640 HYDROXYCARBAMIDE
220021302 220006229 1.53 52 Radical (R) 2014-05-16 2014-06-23 AML MyeChild 01 B Cytarabine/Daunoxome 02 null 220023646 NOT MATCHED
220021303 220006241 1.59 null Disease modification (D) 2016-09-10 2017-01-13 Hydroxycarbamide Y N 220023676 HYDROXYCARBAMIDE
220021304 220006248 1.66 null Palliative (P) 2016-04-01 2017-06-25 Cytarabine Low Dose Y N 220023701 CYTARABINE
220021305 220006258 null 65.1 Curative (C) null 2014-04-03 CYTARABINE N N 220023737 CYTARABINE
220021306 220019492 1.6 52 Disease modification (D) 2014-09-11 2014-09-11 Hydroxycarbamide N N 220023739 HYDROXYCARBAMIDE
220021307 220006263 0 0 Palliative (P) 2015-06-12 2015-07-24 Hydroxycarbamide N N 220023759 HYDROXYCARBAMIDE
220021308 220019493 0 0 Disease modification (D) 2013-08-03 2013-09-28 Hydroxycarbamide 02 N 220023793 HYDROXYCARBAMIDE
220021309 220006277 null 24.8 Curative (C) 2014-11-13 2015-02-05 null null null 220023811 NOT MATCHED
220021310 220006282 0 70.4 Palliative (P) 2018-03-02 2018-03-02 Hydroxycarbamide 2 N 220023821 HYDROXYCARBAMIDE
220021312 220006296 1.05 73.4 Disease modification (D) 2017-12-21 2019-05-20 Hydroxycarbamide N N 220023866 HYDROXYCARBAMIDE
220021313 220006302 0 7.6 Curative (C) 2017-06-17 2017-08-29 AML MyeChild 01 A Mitozantrone/Cytarabine Y N 220023877 NOT MATCHED
220021314 220006317 1.65 76.4 Curative (C) 2017-05-17 2017-05-27 AML MyeChild 01 B Cytarabine/Daunoxome + GO N Y 220023938 NOT MATCHED
220021315 220013424 1.6 null Palliative (P) 2018-04-21 2018-04-26 ALL Ph+ve Dasatinib Continuation 2 N 220024004 NOT MATCHED
220021316 220006336 null 90 Curative (C) 2017-10-05 2017-10-05 Cytarabine Low Dose N null 220024041 CYTARABINE
220021317 220006340 1.62 null Disease modification (D) null 2017-02-25 CYTARABINE N N 220024098 CYTARABINE
220021319 220017348 1.71 101 Palliative (P) 2017-09-27 2017-09-27 Hydroxycarbamide 2 N 220024163 HYDROXYCARBAMIDE
220021320 220006369 null 81.6 Disease modification (D) 2014-09-25 2014-09-25 Cytarabine Low Dose 02 N 220024229 CYTARABINE
220021321 220006378 1.74 null Palliative (P) 2016-08-26 2016-08-27 Hydroxycarbamide 2 N 220024262 HYDROXYCARBAMIDE
220021322 220006387 1.49 null Disease modification (D) null 2015-07-23 Cytarabine Low Dose 99 N 220024304 CYTARABINE
220021323 220006393 0 61 Curative (C) null 2017-05-12 AML MyeChild 01 FLA 2 N 220024319 NOT MATCHED
220021324 220021445 null 13.5 Curative (C) 2015-12-29 2015-12-29 AML MyeChild 01 FLA-Idarubicin 02 N 220024326 NOT MATCHED
220021325 220006407 1.68 null Curative (C) 2015-06-17 2015-08-27 AML MyeChild 01 FLA-Idarubicin N N 220024353 NOT MATCHED
220021326 220017362 null 83.3 Palliative (P) 2015-09-21 2015-09-21 Cytarabine Low Dose N N 220024357 CYTARABINE
220021328 220013486 null 115 Palliative (P) 2014-03-01 2014-03-02 CYTARABINE N N 220024416 CYTARABINE
220021329 220021448 0 0 Disease modification (D) 2018-12-14 2018-12-15 Hydroxycarbamide 2 N 220024432 HYDROXYCARBAMIDE
220021330 220013492 0 null Disease modification (D) 2018-01-03 2018-01-03 Hydroxycarbamide 02 N 220024442 HYDROXYCARBAMIDE
220021332 220013502 1.8 66 Palliative (P) 2014-08-06 2014-09-15 CYTARABINE 02 N 220024482 CYTARABINE
220021333 220006445 1.6 null Disease modification (D) 2015-11-28 2015-12-02 Hydroxycarbamide null null 220024501 HYDROXYCARBAMIDE
220021334 220006455 1.76 74.9 Disease modification (D) 2018-04-06 2018-04-07 Hydroxycarbamide N N 220024528 HYDROXYCARBAMIDE
220021335 220006473 0 25.2 Disease modification (D) 2017-03-12 2017-04-14 FLUDARABINE + THIOTEPA + TREOSULFAN 02 N 220024615 NOT MATCHED
220021336 220006486 1.67 null Disease modification (D) 2014-05-08 2014-05-22 Cytarabine Low Dose 02 null 220024673 CYTARABINE
220021337 220013541 1.54 null Curative (C) 2014-05-23 2014-08-02 Hydroxycarbamide N N 220024689 HYDROXYCARBAMIDE
220021338 220022253 1.67 61.9 Palliative (P) 2019-01-02 2019-03-19 AML MyeChild 01 HD AraC 02 N 220024708 NOT MATCHED
220021339 220013549 1.67 null Palliative (P) 2017-01-21 2017-01-23 Hydroxycarbamide 02 N 220024764 HYDROXYCARBAMIDE
220021341 220006518 null 71 Adjuvant (A) 2013-04-16 2013-04-16 Hydroxycarbamide N null 220024810 HYDROXYCARBAMIDE
220021342 220006519 null 78 Disease modification (D) 2017-04-21 2017-04-21 Hydroxycarbamide N N 220024820 HYDROXYCARBAMIDE
220021343 220022298 1.54 70.9 Disease modification (D) 2015-06-14 2015-10-11 Hydroxycarbamide 2 N 220024847 HYDROXYCARBAMIDE
220021344 220006530 null null Palliative (P) null 2016-09-07 Cytarabine Low Dose null null 220024903 CYTARABINE
220021347 220006554 1.85 0 Palliative (P) 2013-11-11 2014-05-02 Hydroxycarbamide N N 220025054 HYDROXYCARBAMIDE
220021348 220006558 null 57.9 Disease modification (D) 2016-12-05 2017-02-24 Hydroxycarbamide null N 220025077 HYDROXYCARBAMIDE
220021349 220006568 0 null Curative (C) 2016-05-30 2016-07-09 AML MyeChild 01 A Mitozantrone/Cytarabine N N 220025121 NOT MATCHED
220021350 220006578 null null Palliative (P) 2016-12-21 2016-12-22 Cytarabine Low Dose null null 220025174 CYTARABINE
220021351 220006583 null 57.1 Palliative (P) 2017-07-11 2017-07-14 Hydroxycarbamide 1 N 220025180 HYDROXYCARBAMIDE
220021352 220013613 null 89.3 null 2016-05-08 2016-07-12 AML18 PILOT TRIAL Y N 220025353 PILOT TRIAL
220021353 220019557 1.49 98.9 Curative (C) 2016-01-05 2016-04-01 AML 18 TRIAL Y N 220025361 AML18 TRIAL
220021354 220006637 null 51.5 Adjuvant (A) 2015-12-28 2016-01-01 AML18 PILOT TRIAL Y N 220025425 PILOT TRIAL